Showing results (141-150 of 317) with videos related to
Sort By:
Pageof 32
American Journal of Clinical Pathology|October 1, 2016
Effect of On-Site Support on Laboratory Practice for Human Immunodeficiency Virus, Tuberculosis, and Malaria TestingSarah M Burnett, Martin K Mbonye, Robert Martin, et al.Plos One|January 8, 2025
Community pharmacies: Key players in point-of-care diagnostics for STI screening in AfricaAgnes N Kiragga, Annet Onzia, Vivian Nakate, et al.Infection and Immunity|September 24, 2005
Effects of dexamethasone and transient malnutrition on rabbits infected with aerosolized Mycobacterium tuberculosis CDC1551Anup K Kesavan, Susana E Mendez, Christine L Hatem, et al.Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Relationship between acute SARS-CoV-2 viral clearance with Long COVID Symptoms: a cohort studyCarly Herbert, Annukka A R Antar, John Broach, et al.BMC Infectious Diseases|June 2, 2021
Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective studyJuliet Namugenyi, Joseph Musaazi, Achilles Katamba, et al.Plos One|September 16, 2014
Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in UgandaWilly Ssengooba, Lydia Nakiyingi, Derek T Armstrong, et al.International Journal of STD & AIDS|April 23, 2021
Point-of-care testing for HIV and sexually transmitted infections reveals risky behavior among men at gambling centers in Uganda"Agnes N Kiragga, John M Bwanika, Joshua Kyenkya, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2024
Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort StudyCarly Herbert, Annukka A R Antar, John Broach, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settingsDavid B Meya, Yukari C Manabe, Barbara Castelnuovo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2016
Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among Immunocompromised Persons: A Before-After Study in UgandaAgnes N Kiragga, Elizabeth Nalintya, Bozena M Morawski, et al.Pageof 32